BLACKSTONE INC (BX)

US09260D1072 - Common Stock

123.36  -0.42 (-0.34%)

Premarket: 123.19 -0.17 (-0.14%)

Fundamental Rating

4

Overall BX gets a fundamental rating of 4 out of 10. We evaluated BX against 210 industry peers in the Capital Markets industry. While BX is still in line with the averages on profitability rating, there are concerns on its financial health. BX is quite expensive at the moment. It does show a decent growth rate.



6

1. Profitability

1.1 Basic Checks

In the past year BX was profitable.
In the past year BX had a positive cash flow from operations.
In the past 5 years BX has always been profitable.
In the past 5 years BX always reported a positive cash flow from operatings.

1.2 Ratios

BX has a Return On Assets (3.45%) which is comparable to the rest of the industry.
BX's Return On Equity of 20.40% is amongst the best of the industry. BX outperforms 88.46% of its industry peers.
BX has a Return On Invested Capital of 9.99%. This is amongst the best in the industry. BX outperforms 84.13% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BX is significantly above the industry average of 8.34%.
The 3 year average ROIC (19.39%) for BX is well above the current ROIC(9.99%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.45%
ROE 20.4%
ROIC 9.99%
ROA(3y)7.26%
ROA(5y)6.41%
ROE(3y)35.13%
ROE(5y)30.07%
ROIC(3y)19.39%
ROIC(5y)16.24%

1.3 Margins

BX has a Profit Margin (17.34%) which is in line with its industry peers.
BX's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 43.30%, BX is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
BX's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 43.3%
PM (TTM) 17.34%
GM N/A
OM growth 3Y-1.78%
OM growth 5Y-3.22%
PM growth 3Y0.41%
PM growth 5Y-5.14%
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

BX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BX has been increased compared to 5 years ago.
Compared to 1 year ago, BX has an improved debt to assets ratio.

2.2 Solvency

BX has an Altman-Z score of 3.14. This indicates that BX is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.14, BX is doing good in the industry, outperforming 78.85% of the companies in the same industry.
The Debt to FCF ratio of BX is 2.95, which is a good value as it means it would take BX, 2.95 years of fcf income to pay off all of its debts.
BX's Debt to FCF ratio of 2.95 is fine compared to the rest of the industry. BX outperforms 77.88% of its industry peers.
BX has a Debt/Equity ratio of 1.66. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.66, BX is doing worse than 73.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.66
Debt/FCF 2.95
Altman-Z 3.14
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

BX has a Current Ratio of 0.75. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
BX has a worse Current ratio (0.75) than 68.75% of its industry peers.
A Quick Ratio of 0.75 indicates that BX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.75, BX is doing worse than 68.27% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75

5

3. Growth

3.1 Past

The earnings per share for BX have decreased strongly by -23.60% in the last year.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.85% yearly.
The Revenue has decreased by -5.81% in the past year.
Measured over the past years, BX shows a small growth in Revenue. The Revenue has been growing by 3.26% on average per year.
EPS 1Y (TTM)-23.6%
EPS 3Y14.23%
EPS 5Y10.85%
EPS growth Q2Q3.74%
Revenue 1Y (TTM)-5.81%
Revenue growth 3Y9.55%
Revenue growth 5Y3.26%
Revenue growth Q2Q-24.59%

3.2 Future

The Earnings Per Share is expected to grow by 14.21% on average over the next years. This is quite good.
The Revenue is expected to grow by 17.18% on average over the next years. This is quite good.
EPS Next Y28.95%
EPS Next 2Y26.36%
EPS Next 3Y21.89%
EPS Next 5Y14.21%
Revenue Next Year26.33%
Revenue Next 2Y23.57%
Revenue Next 3Y19.68%
Revenue Next 5Y17.18%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

BX is valuated quite expensively with a Price/Earnings ratio of 31.23.
Based on the Price/Earnings ratio, BX is valued a bit more expensive than the industry average as 77.88% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 25.20, BX is valued a bit more expensive.
BX is valuated rather expensively with a Price/Forward Earnings ratio of 24.22.
Based on the Price/Forward Earnings ratio, BX is valued a bit more expensive than the industry average as 69.71% of the companies are valued more cheaply.
BX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.63.
Industry RankSector Rank
PE 31.23
Fwd PE 24.22

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BX.
60.58% of the companies in the same industry are cheaper than BX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 39.46
EV/EBITDA 45.33

4.3 Compensation for Growth

BX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
BX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 21.89% in the coming years.
PEG (NY)1.08
PEG (5Y)2.88
EPS Next 2Y26.36%
EPS Next 3Y21.89%

3

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 2.71%. Purely for dividend investing, there may be better candidates out there.
BX's Dividend Yield is slightly below the industry average, which is at 7.77.
Compared to an average S&P500 Dividend Yield of 2.44, BX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.71%

5.2 History

The dividend of BX has a limited annual growth rate of 5.34%.
BX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

306.88% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP306.88%
EPS Next 2Y26.36%
EPS Next 3Y21.89%

BLACKSTONE INC

NYSE:BX (4/25/2024, 7:04:01 PM)

Premarket: 123.19 -0.17 (-0.14%)

123.36

-0.42 (-0.34%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap151.23B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 2.71%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 31.23
Fwd PE 24.22
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.08
PEG (5Y)2.88
Profitability
Industry RankSector Rank
ROA 3.45%
ROE 20.4%
ROCE
ROIC
ROICexc
ROICexgc
OM 43.3%
PM (TTM) 17.34%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.66
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-23.6%
EPS 3Y14.23%
EPS 5Y
EPS growth Q2Q
EPS Next Y28.95%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-5.81%
Revenue growth 3Y9.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y